Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma.

The Journal of Urology
Nicholas J HellenthalHyung L Kim

Abstract

Sunitinib is an approved treatment for metastatic renal cell carcinoma. We performed a prospective clinical trial to evaluate the safety and clinical response to sunitinib administered before nephrectomy in patients with localized or metastatic clear cell renal cell carcinoma. Patients with biopsy proven clear cell renal cell carcinoma were enrolled in the study and treated with 37.5 mg sunitinib malate daily for 3 months before nephrectomy. The primary end point was safety. In an 18-month period 20 patients were enrolled. The most common toxicities were gastrointestinal symptoms and hematological effects. Grade 3 toxicity developed in 6 patients (30%). No surgical complications were attributable to sunitinib treatment. Of the 20 patients 17 (85%) experienced reduced tumor diameter (mean change -11.8%, range -27% to 11%) and cross-sectional area (mean change -27.9%, range -43% to 23%). Enhancement on contrast enhanced computerized tomography decreased in 15 patients (mean HU change -22%, range -74% to 29%). After tumor reduction 8 patients with cT1b disease underwent laparoscopic partial nephrectomy. Surgical parameters, such as blood loss, transfusion rate, operative time and complications, were similar to those in patients wh...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A RabinovitchZ Fuks
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerBrian I Rini
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Robert J MotzerM Dror Michaelson
Sep 21, 2006·Journal of the National Cancer Institute·John M HollingsworthBrent K Hollenbeck
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
May 12, 2007·European Urology·Paul C M S Verhagen
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Astrid A M van der VeldtEpie Boven
Sep 4, 2008·Current Oncology Reports·Naomi B Haas, Robert Uzzo
Apr 18, 2009·The Journal of Urology·Hyung L KimGregory E Wilding
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric JonaschNizar Tannir

❮ Previous
Next ❯

Citations

Oct 20, 2011·Der Urologe. Ausg. A·M W KramerM A Kuczyk
Apr 13, 2011·Targeted Oncology·Sumanta Kumar Pal, Robert A Figlin
Jun 5, 2013·Indian Journal of Surgical Oncology·Ginil Kumar PooleriAppu Thomas
Feb 27, 2013·World Journal of Urology·Axel Bex, John Haanen
Apr 23, 2014·Nature Reviews. Urology·Edwin M Posadas, Robert A Figlin
Feb 18, 2014·Cancer Chemotherapy and Pharmacology·Xavier García Del MuroDaniel Castellano
Oct 19, 2014·Journal of the National Cancer Institute·Philip WongDian Wang
Dec 12, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·F A CalvoJ M Berian
May 2, 2012·Journal of Cancer Research and Clinical Oncology·Kwang Hyun KimChoung-Soo Kim
Jan 20, 2016·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P BigotJ-J Patard
Feb 19, 2013·Urology·Raoul R Salup
May 25, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Tomoaki FujiokaUNKNOWN Committee for Establishment of the Clinical Practice Guideline for the Management of Renal Cell Carcinoma and the Japanese U
Nov 21, 2012·The British Journal of Surgery·T Waddell, D Cunningham
May 30, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Andres J SchraderMarkus A Kuczyk
Sep 9, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshihiko Tomita
Aug 5, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Axel BexJose A Karam
Aug 30, 2013·Expert Opinion on Pharmacotherapy·Edwin M PosadasRobert A Figlin
Dec 27, 2011·Expert Opinion on Pharmacotherapy·Eduard VrdoljakLaszlo Torday
Nov 10, 2015·Journal of the National Cancer Institute·Benjamin CarlisleJonathan Kimmelman
Dec 15, 2016·Expert Review of Anticancer Therapy·Elise NassifStéphane Oudard
Apr 17, 2017·The Urologic Clinics of North America·Sumi DeyBrian R Lane
Apr 2, 2016·Therapeutic Advances in Urology·Leonardo D BorregalesJose A Karam
Jul 23, 2014·Urologia·Stefano RicciardulliAntonio Celia
Mar 20, 2012·The Journal of Urology·Brian I RiniSteven Campbell
Jan 24, 2019·Expert Review of Anticancer Therapy·Jarred P ReedRobert A Figlin
Apr 4, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Sean W BerquistIthaar H Derweesh
May 20, 2015·Der Urologe. Ausg. A·M A ReiterA Haferkamp
Jun 15, 2019·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Alberto Diaz de LeonIvan Pedrosa
Dec 21, 2012·Expert Review of Anticancer Therapy·Marc-Olivier TimsitBernard Escudier
Jun 22, 2012·Expert Review of Anticancer Therapy·Kiruthikah ThillaiSimon Chowdhury
Jan 8, 2014·Expert Review of Anticancer Therapy·Myria GalaziSimon Chowdhury
May 31, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·T AssiJ Kattan
Jun 22, 2012·Expert Review of Anticancer Therapy·Axel Bex, Tom Powles
May 7, 2019·Journal of Oncology·Fady GhaliIthaar H Derweesh
Nov 3, 2016·BJU International·Alessandro LarcherUmberto Capitanio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.